Obesity significantly contributes to heart failure morbidity and mortality, necessitating integrated management strategies for affected patients.
This review provides a comprehensive guide on managing patients with both obesity and heart failure, emphasizing the need for integrated strategies spanning lifestyle, pharmacological, and surgical interventions.
Absolute Event Rate: 0% vs 0%
Obesity is a key contributor to heart failure, driving increased morbidity, mortality, and healthcare costs. This association is supported by multiple pathophysiological mechanisms and consistent epidemiological evidence, particularly not only in heart failure with preserved ejection fraction (HFpEF), but also in heart failure with reduced ejection fraction (HFrEF). Given the rising prevalence of both diseases, integrated management strategies are essential. This review outlines current management options in patients with heart failure and obesity, from lifestyle modification to pharmacological and surgical treatment, and explores emerging treatments aimed at mitigating this growing burden.
Antza et al. (Tue,) reported a other. Obesity significantly contributes to heart failure morbidity and mortality, necessitating integrated management strategies for affected patients.